{"id":"W296622129","doi":"","title":"A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Treatment of Major Depression","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Tolerability; Major depressive disorder; Milnacipran; Hazard ratio; Randomized controlled trial; Montgomery–Åsberg Depression Rating Scale; Psychiatry; Internal medicine; Placebo-controlled study; Physical therapy; Confidence interval; Adverse effect; Double blind; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001990751,0.001725591,0.0029528,0.0004808455,0.0006288373,0.0008054859,0.0009779549,0.001818426,0.006166072],"category_scores_gemma":[0.002254724,0.0009151084,0.001341171,0.00038416,0.001439287,0.0008678206,0.0003742476,0.002621805,0.001008515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007020517,"about_ca_system_score_gemma":0.001411499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001130017,"about_ca_topic_score_gemma":0.002581365,"domain_scores_codex":[0.999162,0.0004568663,0.00005643526,0.0001691214,0.00006027829,0.0000953025],"domain_scores_gemma":[0.9988153,0.0003228202,0.0002841709,0.00009916833,0.00008592803,0.0003925566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857481,0.005713574,0.0002286684,0.0003178321,0.0003641073,0.00002210861,0.00002334745,0.00009216351,0.001688191,0.00004361608,0.0003677162,0.005390574],"study_design_scores_gemma":[0.9691879,0.02969072,0.0005565361,0.00001151986,0.0001160855,0.00001031716,0.000005059472,0.0001403174,0.0001229595,0.0000316268,0.0001223936,0.000004628015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801451,0.004059608,0.0008071372,0.0007696606,0.0008269835,0.009619327,0.001403481,0.000237838,0.002130825],"genre_scores_gemma":[0.9807125,0.00233236,0.002025906,0.001303048,0.0005407113,0.009028535,0.00111059,0.00002610347,0.002920322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006166072,"threshold_uncertainty_score":0.02062756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01408517879030637,"score_gpt":0.2510077054521628,"score_spread":0.2369225266618564,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}